MENUNews Archive
Date: 08/16/2013
Xofigo, a newly approved treatment for advanced prostate cancer, delivers a powerful punch of radiation directly to tumor cells that have invaded the bone.
Date: 08/03/2013
Many of breast cancer patients will receive aggressive treatments that could have little to no effect on their survival.
Date: 08/03/2013
Results from research at the University of Michigan indicate that if mice have healthy gastrointestinal tract, the chances of surviving high doses of chemotherapy increase.
Date: 07/24/2013
OncoMed Pharmaceuticals, a company started at the University of Michigan in 2004, raised $82 million in an initial public offering.
Date: 07/24/2013
A new, high-risk prostate cancer clinic is available at the University of Michigan Rogel Cancer Center for men with fast-growing prostate cancer.
Date: 07/09/2013
Certain chronic conditions for which urology practices are well-suited, and in some cases, better equipped, to carry out medical home functions compared to their primary care counterparts, according to a new study led by researchers from the University of Michigan.
Date: 06/26/2013
Despite being unlikely to benefit, more patients with low risk prostate cancer receiving advanced procedures according to new University of Michigan study in JAMA.
Date: 06/26/2013
University of Michigan Rogel Cancer Center researchers believe killing stem cells is key to improving cancer treatment.
Date: 06/20/2013
Dr. Weizer is an associate professor of urology at the U-M Medical School. His appointment is effective June 17, 2013.